Evidence map›Paper›PMID 24360956›Full record

ArticleCell reports2013

Dynamic chromatin modification sustains epithelial-mesenchymal transition following inducible expression of Snail-1.

Sarah Javaid, Jianmin Zhang, Endre Anderssen, Josh C Black, Ben S Wittner, Ken Tajima, David T Ting, Gromoslaw A Smolen, Matthew Zubrowski, Rushil Desai and 4 more

Abstract read
In one paragraph

Article in Cell reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Sarah JavaidMassachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA 02129, USA.
Jianmin ZhangMassachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA 02129, USA.
Endre AnderssenMassachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA 02129, USA.
Josh C BlackMassachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA 02129, USA.
Ben S WittnerMassachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA 02129, USA.
Ken TajimaMassachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA 02129, USA.
David T TingMassachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA 02129, USA.
Gromoslaw A SmolenMassachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA 02129, USA.
Matthew ZubrowskiMassachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA 02129, USA.
Rushil DesaiMassachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA 02129, USA.
Shyamala MaheswaranMassachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA 02129, USA.
Sridhar RamaswamyMassachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA 02129, USA.
Johnathan R WhetstineMassachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA 02129, USA.
Daniel A HaberMassachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA 02129, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA. Electronic address: haber@helix.mgh.harvard.edu.

Funding

Modeling Metastasis and Acquired Drug Resistance Using Circulating Tumor CellsR01CA129933 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI Daniel A. Haber · 2008 to 2026
$7.5M
Understanding the Role of Histone Demethylases and Heterochromatin in Cell CycleR01GM097360 · NIGMS · RESEARCH INST OF FOX CHASE CAN CTR · PI WHETSTINE, JOHNATHAN R. · 2012 to 2020
$3.4M
PROTON THERAPY RESEARCH AND TREATMENT CENTERC06CA059267 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI GOITEIN, MICHAEL · 1992 to 1995
–
Howard Hughes Medical InstituteNCI NIH HHS C06 CA059267NCI NIH HHS CA059267NCI NIH HHS CA129933NCI NIH HHS R01 CA129933NIGMS NIH HHS R01 GM097360NIGMS NIH HHS R01GM097360
6 · The paper itself

Abstract

Epithelial-mesenchymal transition (EMT) is thought to contribute to cancer metastasis, but its underlying mechanisms are not well understood. To define early steps in this cellular transformation, we analyzed human mammary epithelial cells with tightly regulated expression of Snail-1, a master regulator of EMT. After Snail-1 induction, epithelial markers were repressed within 6 hr, and mesenchymal genes were induced at 24 hr. Snail-1 binding to its target promoters was transient (6-48 hr) despite continued protein expression, and it was followed by both transient and long-lasting chromatin changes. Pharmacological inhibition of selected histone acetylation and demethylation pathways suppressed the induction as well as the maintenance of Snail-1-mediated EMT. Thus, EMT involves an epigenetic switch that may be prevented or reversed with the use of small-molecule inhibitors of chromatin modifiers.

Indexed as

Chromatin Assembly and DisassemblyEpithelial-Mesenchymal TransitionProtein Processing, Post-TranslationalAcetylationCarcinogenesisChromatinEpigenesis, GeneticEpithelial CellsGene Expression Regulation, NeoplasticHistone Deacetylase InhibitorsHistone DeacetylasesHumansMCF-7 CellsMethylationPromoter Regions, GeneticSnail Family Transcription FactorsChromatinHistone Deacetylase InhibitorsHistone DeacetylasesSNAI1 protein, humanSnail Family Transcription FactorsTranscription Factors

Identifiers

PMID24360956
PMCPMC4034764

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.